Virus Diseases  >>  inactivated VZV vaccine (V212)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
inactivated VZV vaccine (V212) / Merck (MSD)
NCT02180295 / 2014-001030-29: A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)

Withdrawn
3
0
US
V212 Lot 1, V212 Lot 2, V212 Lot 3
Merck Sharp & Dohme LLC
Herpes Zoster
03/15
03/15

Download Options